A recent study reveals that people who discontinue popular GLP-1 drugs like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who halt conventional diet and exercise regimens.
Published data in a leading health publication points out that while overweight individuals frequently drop a large proportion of their body weight while on the medication, the mass comes back at an estimated rate of nearly a kilo each month after stopping.
"People buying such treatments need to be cognizant of the potential of rapid weight regain when the medication ends," cautioned researcher Dr. Susan Jebb.
Such speed of recovery suggests a return to starting mass within about one and a half years.
Weighing Approaches
The research, which looked at 37 of studies involving over 9,000 of patients, contrasted the effects of the injectable medications with other pills.
Researchers point out that people who shed pounds through diet and exercise usually have a slower creep back—perhaps 100 grams monthly—once they finish.
Understanding the Rapid Regain
Doctors propose the mechanism of the injections explains the accelerated rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 concentrations far above than normal may cause the system to produce less of its own natural GLP-1, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.
"Stopping of this hormone supplement leads to hunger is uncontrolled, making binge eating much more probable."
An Ongoing Issue?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.
Many experts say that, given the significant potential of weight regain, the treatment should be considered long-term.
This perspective is supported by drug manufacturers, who state that the results "highlight the chronic nature of excess weight," similar to managing diseases like hypertension.
Patient Experiences
People who have come off the jabs describe a intense resurgence of cravings.
"It was like a switch activating and I was suddenly extremely hungry," described an individual.
This difficulty is compounded if individuals have not adopted lasting dietary or behavioural modifications during therapy.
Widespread Adoption
Figures suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.
- Adoption is more common among women than men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion obtain the drugs through private healthcare rather than public health services.
Ultimately, clinicians caution that while the jabs are effective tools for weight loss, they are not a magic fix and long-term success relies on integrated lifestyle management.
